The blog is a place to post your thoughts and ideas.

The Economist interviewed friend and collaborator Petra Klepac on optimal vaccination strategies, asking, under what circumstances does it make good economic and epidemiological sense to invest your resources in vaccinating neighboring communities?

Earlier this week, the FDA announced new restrictions on the use of cephalosporins in livestock – big news for an agency that just before the holidays withdrew two 1977 proposals to restrict certain uses of penicillins and tetracyclines in animal feed and food-producing animals.

It’s been a fall of mixed news on antibiotic use in the agricultural industry in the United States.  Advocates of restricting the practice balked at the FDA’s rejection, in November, of two citizen petitions enlisting the agency’s help in banning certain uses of antibiotics for livestock due to concerns about emerging antibiotic resistance.

The GrantWatch blog at Health Affairs has a new post detailing some initiatives from CDDEP's Extending the Cure project: antibiotic use visualizations on ResistanceMap and the Drug Resistance Index.  An excerpt of the post is below - read it in its entirety on the Gran

The Defense Advanced Research Projects Agency (DARPA) has put out a call for research to develop a novel kind of bacteria-fighting mechanism, and it was the focus of the most recent Science Friday.  It’s nanotechnology’s response to antibiotic resistance, and it involves little bits of RNA, attached to nanoparticles, that can “turn off” antibiotic resistance within bacterial cells or stop replication. 

ResistanceMap's data visualizations on outpatient antibiotic consumption in the United States have been making waves in the U.S.

The following post originally appeared on CDC's Safe Healthcare blog.

The following interview with Ramanan Laxminarayan, Director of CDDEP and its Extending the Cure project, originally appeared on the NewPublicHealth blog of the Robert Wood Johnson Foundation.